JP2023554322A5 - - Google Patents

Info

Publication number
JP2023554322A5
JP2023554322A5 JP2023535375A JP2023535375A JP2023554322A5 JP 2023554322 A5 JP2023554322 A5 JP 2023554322A5 JP 2023535375 A JP2023535375 A JP 2023535375A JP 2023535375 A JP2023535375 A JP 2023535375A JP 2023554322 A5 JP2023554322 A5 JP 2023554322A5
Authority
JP
Japan
Prior art keywords
optionally substituted
compound
alkyl
formula
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023535375A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023554322A (ja
JP7840959B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/085082 external-priority patent/WO2022122975A1/en
Publication of JP2023554322A publication Critical patent/JP2023554322A/ja
Publication of JP2023554322A5 publication Critical patent/JP2023554322A5/ja
Application granted granted Critical
Publication of JP7840959B2 publication Critical patent/JP7840959B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023535375A 2020-12-09 2021-12-09 シクロペンテノン誘導体及び抗生物質としてのその使用 Active JP7840959B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20306525.5 2020-12-09
EP20306525 2020-12-09
PCT/EP2021/085082 WO2022122975A1 (en) 2020-12-09 2021-12-09 Cyclopentenones derivatives and their use as antibiotics

Publications (3)

Publication Number Publication Date
JP2023554322A JP2023554322A (ja) 2023-12-27
JP2023554322A5 true JP2023554322A5 (enExample) 2024-12-17
JP7840959B2 JP7840959B2 (ja) 2026-04-06

Family

ID=74129992

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023535375A Active JP7840959B2 (ja) 2020-12-09 2021-12-09 シクロペンテノン誘導体及び抗生物質としてのその使用

Country Status (5)

Country Link
US (1) US12612354B2 (enExample)
EP (1) EP4259114A1 (enExample)
JP (1) JP7840959B2 (enExample)
CA (1) CA3203656A1 (enExample)
WO (1) WO2022122975A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4316476A1 (en) * 2022-08-02 2024-02-07 University of Crete Anticancer agents based on cyclopentenones

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100570936B1 (ko) * 1997-03-05 2006-04-13 다카라 바이오 가부시키가이샤 시클로펜텐 고리 또는 시클로펜탄 고리를 갖는 화합물
JPH1143460A (ja) * 1997-07-28 1999-02-16 Taisho Pharmaceut Co Ltd フェニル置換ヒドロキシシクロペンテノン類縁体
JP2003532698A (ja) 2000-05-10 2003-11-05 プリンストン ユニバーシティ 細菌の増殖および病理発生を調節するための化合物ならびに方法
GB0116594D0 (en) 2001-07-06 2001-08-29 Cancer Res Ventures Ltd Therapeutic compounds
AU2002352402A1 (en) 2001-12-14 2003-06-30 Charterhouse Therapeutics Limited Improvements in pharmaceutical compositions
GB0901834D0 (en) 2009-02-04 2009-03-11 Syngenta Ltd Novel herbicides
CA2761685A1 (en) 2009-05-16 2010-11-25 Syngenta Limited Novel herbicides
JP2013514293A (ja) 2009-12-18 2013-04-25 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 有害生物の対処および防除方法
FR3020809B1 (fr) * 2014-05-06 2016-06-03 Centre Nat Rech Scient Derives de 4-vinyl-2cyclopentene-1-one leur preparation et leur utilisation en tant qu'agent antibiotique
CN107141227B (zh) 2016-09-05 2019-05-17 香港科技大学深圳研究院 一种手性4-胺基环戊烯酮的制备方法及其应用

Similar Documents

Publication Publication Date Title
JP2020169171A5 (enExample)
DE69316240T2 (de) Durch eine tropon gruppe substituierte phenyloxazolidinone-derivate als antibakterielles mittel
JP2024522766A5 (enExample)
JP2024512154A5 (enExample)
RU2395500C2 (ru) 2,4-пиримидиндиамины, применяемые в лечении неопластических болезней, воспалительных и иммунных расстройств
KR20220158761A (ko) 사이클로스포린 유도체의 제조
CA2517020A1 (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
JP2023512213A5 (enExample)
JP6031122B2 (ja) 抗微生物療法のための三環式ホウ素化合物
NZ585701A (en) Benzopyrazine derivatives as prolyl hydroxylase inhibitors
JP2021523200A5 (enExample)
JP2019518766A5 (enExample)
JP2014509322A5 (enExample)
AR067896A1 (es) Procedimiento para sintetizar compuestos utiles para tratar hepatitis c
SK50793A3 (en) Method for preparing taxane derivatives, novel derivatives thereby obtained and pharmaceutical compositions containing same
RU2639153C2 (ru) Трициклическое бензоксабороловое соединение, способ его получения и его применение
JP2005514398A5 (enExample)
JP2020122016A5 (enExample)
JP2009538910A5 (enExample)
JP2019518050A5 (enExample)
DE69622933T2 (de) Prodrugs von Paclitaxel-Derivaten
JP2025517106A5 (enExample)
JP2023554322A5 (enExample)
JP4707393B2 (ja) 抗癌化合物
JP2024534420A5 (enExample)